Shreya Madhavaram
Rheumatology · New Orleans, LANPI 1093205072
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,836 of the $4,645 with a category attached, or 82.6%. 27 manufacturers reported payments, led by Novartis at 32.2% of the total. 2025 is the largest year on record at $3,166, 5.5 times the $571 reported in 2019. That places this record below the midpoint for rheumatology clinicians in LA, where the typical reported total is $8,351.
Across 134 payments — averaging $34.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AstraZeneca$401
- Johnson & Johnson$394
- Amgen$335
- AbbVie$254
- UCB, Inc.$245
- plus $2K from 21 others
What the payments were for
- Travel & lodging$70915%
- Food & beverage$3,83683%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $1,497 |
| AstraZeneca(2 entities) | 17 | $401 |
| Johnson & Johnson(2 entities) | 16 | $394 |
| Amgen | 11 | $335 |
| AbbVie | 9 | $254 |
| UCB, Inc. | 7 | $245 |
| Mallinckrodt Hospital Products Inc. | 5 | $231 |
| Sanofi | 3 | $219 |
| E.r. Squibb & Sons, L.L.C. | 17 | $213 |
| Aurinia Pharma U.S., Inc. | 5 | $175 |
| Pfizer | 11 | $159 |
| Janssen Scientific Affairs, LLC | 4 | $106 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| GSK | 2 | $45 |
| Genentech USA, Inc. | 2 | $35 |
| Sobi, Inc | 1 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Octapharma USA, Inc. | 1 | $20 |
| Viiv Healthcare Company | 1 | $20 |
| Biogen | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Bayer | 1 | $15 |
| Ardelyx, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,645 in reported general payments places this provider in the 35th percentile of 88 rheumatology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 16 | $139,888 |
| HumiraAdalimumab | 18 | $121,782 |
| Enbrel SureclickEtanercept | 11 | $77,774 |
| Hydroxychloroquine Sulfate | 58 | $1,557 |
| Colchicine | 15 | $1,349 |
| MethotrexateMethotrexate Sodium | 38 | $1,137 |
| Allopurinol | 36 | $564 |
| Prednisone | 61 | $431 |
| Celecoxib | 25 | $299 |
| Diclofenac Sodium | 11 | $263 |
| Gabapentin | 27 | $199 |
| Alendronate Sodium | 13 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira | $254 | $121,78218 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $17 | $1,34915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 88 rheumatology providers in Louisiana.
Other rheumatology in New Orleans
- Lesley SaketkooNew Orleans$97K
- Evangeline ScopelitisNew Orleans$96K
- William DavisNew Orleans$37K
- Barrett FordNew Orleans$16K
- Luis EspinozaNew Orleans$11K
- Mansour AlghamdiNew Orleans$9K
- Nirupa PatelNew Orleans$7K
- Laura RiversNew Orleans$6K
- Aaron BroadwellShreveport$1.6M
- Ladislas LazaroLafayette$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.